Noked Israel’s Biogen BIIB Stock Holding History

Noked Israel’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,050	Closed	-$485K	–	85
2019 Q1	$485K	Sell	2,050 -950	-32%	-$299K	0.51%	38
2018 Q4	$903K	Buy	+3,000	New	+$957K	0.76%	14

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Noked Israel's BIIB Position: Q2 2019 in Review

Noked Israel sold out of Biogen (BIIB) in Q2 2019, closing a stake of 2,050 shares — an estimated $485K sold.

Noked Israel first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $903K in Q4 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

Noked Israel reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
Noked Israel sold 2,050 Biogen shares in Q2 2019, an estimated $485K.
Noked Israel first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
Noked Israel's Biogen position peaked at $903K in Q4 2018.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Noked Israel's 13F filing for Q2 2019, filed 15 Aug 2019.